BioSante Pharmaceuticals, Inc. (BPAX) Investor Lawsuit and Deadline on April 6 Announced by Shareholders Foundation
(firmenpresse) - SAN DIEGO, CA -- (Marketwire) -- 03/13/12 -- The Shareholders Foundation, Inc. announces that a lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of certain investors in shares of BioSante Pharmaceuticals, Inc. (BPAX) against BioSante Pharmaceuticals, Inc. over alleged Violations of Federal Securities Laws in connection with allegedly false and misleading statements.
A deadline to get actively involved is coming up on April 6, 2012.
Investors with a substantial investment in BioSante Pharmaceuticals, Inc. (BPAX) shares between February 12, 2010 and December 15, 2011, have certain options and should contact the Shareholders Foundation by e-mail at or call +1 (858) 779-1554.
The plaintiff alleges on behalf of all persons or entities who purchased or otherwise acquired the securities of BioSante Pharmaceuticals, Inc. (BPAX) between February 12, 2010 and December 15, 2011, that BioSante Pharmaceuticals, along with its Chief Executive Officer violated the Securities Exchange Act of 1934. Specifically, the plaintiff alleges that the defendants issued a series of materially false and misleading statements to investors about LibiGel's commercial viability, effectiveness, and market potential that caused shares of BioSante Pharmaceuticals to trade at artificially high prices between February 12, 2010 and December 15, 2011.
On December 14, 2011, BioSante Pharmaceuticals, Inc announced the results from LibiGel Efficacy Trials. BioSante Pharmaceuticals, Inc. (BPAX) said that the initial analysis of the data from these trials shows that the trials did not meet the co-primary or secondary endpoints.
Shares of BioSante Pharmaceuticals, Inc. (BPAX) dropped from $2.50 on December 14, 2011, to $0.48 per share on December 15, 2011.
Those who purchased BioSante Pharmaceuticals, Inc. (BPAX) shares have certain options and should contact the Shareholders Foundation.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Trevor Allen
+1 (858) 779-1554
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.03.2012 - 13:48 Uhr
Sprache: Deutsch
News-ID 124268
Anzahl Zeichen: 0
contact information:
Town:
SAN DIEGO, CA
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 131 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioSante Pharmaceuticals, Inc. (BPAX) Investor Lawsuit and Deadline on April 6 Announced by Shareholders Foundation"
steht unter der journalistisch-redaktionellen Verantwortung von
Shareholders Foundation, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
